CIT · Cit Group Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|
| Revenue | $3.15B | $3.29B | $3.27B | $3.21B | $3.09B | $3.88B |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | - | - | $1.05B | $1.11B | $1.22B | - |
| Total Operating Expenses | $1.31B | $1.11B | $1.07B | $1.19B | $1.28B | $1.17B |
| D&A | $327.40M | $308.60M | $606.70M | - | - | - |
| Operating Income | ($703.40M) | $623.90M | $637.00M | $191.60M | $20.90M | $734.20M |
| Interest Expense | $733.30M | $952.00M | $815.10M | $717.70M | $753.20M | $1.10B |
| Income Tax | ($88.10M) | $94.50M | $164.90M | ($67.80M) | $203.50M | ($488.40M) |
| Net Income | ($615.30M) | $529.90M | $447.10M | $468.20M | ($848.00M) | $1.06B |
| EPS - Basic | ($6.57) | $5.30 | $3.64 | $2.82 | ($4.20) | $5.70 |
| EPS - Diluted | ($6.57) | $5.27 | $3.61 | $2.80 | ($4.20) | $5.67 |
Balance Sheet
| Line item | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | - | - | - | $1.59B | $6.38B | $7.47B |
| Accounts Receivable | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - |
| Total Assets | $58.11B | $50.83B | $48.54B | $49.28B | $64.17B | $67.50B |
| Current Liabilities | - | - | - | - | - | - |
| Long-term Debt | $5.84B | $6.47B | $8.12B | $8.97B | $14.94B | $18.54B |
| Total Liabilities | $52.38B | $44.49B | $42.59B | $41.96B | $54.17B | $56.52B |
| Stockholders' Equity | $5.72B | $6.34B | $5.95B | $7.32B | $10.00B | $10.98B |
| Retained Earnings | $1.43B | $2.31B | $1.92B | $1.91B | $1.55B | $2.56B |
Cash Flow
| Line item | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $480.40M | $927.20M | $982.50M | $519.80M | $2.37B | $1.16B |
| Investing Cash Flow | $1.19B | ($1.95B) | $43.80M | $7.76B | ($498.90M) | $1.16B |
| Financing Cash Flow | ($345.70M) | $1.91B | ($942.10M) | ($13.07B) | ($2.93B) | ($997.30M) |
| CapEx | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - |
Ratios
| Metric | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | - | - | - | - | - | - |
| Operating margin | -22.3% | 19.0% | 19.5% | 6.0% | 0.7% | 18.9% |
| EBITDA margin | -11.9% | 28.3% | 38.0% | - | - | - |
| Net margin | -19.5% | 16.1% | 13.7% | 14.6% | -27.4% | 27.2% |
| Free cash flow margin | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | - | - | 32.0% | 34.6% | 39.5% | - |
| Effective tax rate | - | 15.1% | 26.9% | -16.9% | - | -86.0% |
| Return on assets | -1.1% | 1.0% | 0.9% | 1.0% | -1.3% | 1.6% |
| Return on equity | -10.8% | 8.4% | 7.5% | 6.4% | -8.5% | 9.6% |
| Return on invested capital | -4.8% | 4.1% | 3.3% | 1.2% | 0.1% | 2.5% |
| Liquidity | ||||||
| Current ratio | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - |
| Leverage | ||||||
| Debt / Equity | 1.02 | 1.02 | 1.37 | 1.23 | 1.49 | 1.69 |
| Debt / Assets | 0.10 | 0.13 | 0.17 | 0.18 | 0.23 | 0.27 |
| Debt / EBITDA | - | 6.94 | 6.53 | - | - | - |
| Interest coverage | -1.0x | 0.7x | 0.8x | 0.3x | 0.0x | 0.7x |
| Equity multiplier | 10.15 | 8.02 | 8.16 | 6.73 | 6.42 | 6.15 |
| Liabilities / Assets | 0.90 | 0.88 | 0.88 | 0.85 | 0.84 | 0.84 |
| Efficiency | ||||||
| Asset turnover | 0.05 | 0.06 | 0.07 | 0.07 | 0.05 | 0.06 |
| Inventory turnover | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | -4.2% | 0.5% | 2.1% | 3.7% | -20.4% | 7.2% |
| Revenue CAGR (3y) | -0.6% | 2.1% | -5.6% | -4.0% | 8.7% | 48.2% |
| Revenue CAGR (5y) | -4.1% | -1.9% | 6.3% | 21.9% | 4.6% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - |
| Operating income growth (YoY) | - | -2.1% | 232.5% | 816.7% | -97.2% | 7.8% |
| Net income growth (YoY) | - | 18.5% | -4.5% | - | - | -6.6% |
| EPS growth (YoY) | - | 46.0% | 28.9% | - | - | -4.9% |
| EPS CAGR (3y) | - | - | -14.0% | -22.3% | - | - |
| EPS CAGR (5y) | - | -2.4% | 1.5% | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - |
| Book value growth (YoY) | -9.7% | 6.6% | -18.8% | -26.8% | -8.9% | 21.1% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2020-12-31.
Geographic
$3.15B totalUS$3.06B · 97.2%
Non Us$87.50M · 2.8%
Stability scores
Piotroski F-score
FY 2020 · 9-point quality
3/9
Weak
- ✗Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- ✓Long-term debt decreased
- -Current ratio improved
- ✗No share dilution
- -Gross margin improved
- ✗Asset turnover improved
Peer comparison
Same SIC group: National Commercial Banks
Comparing CIT GROUP INC against the 5 most active filers in the same SIC group.